In particular, artesunate, one of the most popular artemisinins, can trigger ferroptosis in KRAS-mutant PDA cancer cells by increasing the intracellular levels of free iron (Eling et al., 2015; Wang et al., 2019d). Here, KRAS is linked to Patent ductus arteriosus.